Real-time enrollment status for this leukemia, acute clinical trial
Current Status
Recruiting
Checked: July 16, 2026 at 11:07 PM UTC
| NCT Number | NCT03680677 |
| Recruiting Status | Recruiting |
| Condition | Leukemia, Acute |
| Phase | Clinical Trial |
| Target Enrollment | 20 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Abramson Cancer Center at Penn Medicine |
| Last Updated on CT.gov | July 31, 2025 (Jul 31, 2025) |
As of July 16, 2026: Clinical trial NCT03680677 is currently recruiting participants. This clinical trial study for leukemia, acute is actively seeking new participants at 1 location across the United States. The study is sponsored by Abramson Cancer Center at Penn Medicine. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT03680677 is actively recruiting participants as of July 16, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT03680677 was last updated Jul 31, 2025 (July 31, 2025). HelloStudys verifies this status automatically.